Abstract
Newborn screening in Alaska includes screening for carnitine palmitoyltransferase 1A (CPT1A) deficiency. The CPT1A Arctic variant is a variant highly prevalent among Indigenous peoples in the Arctic. In this study, we sought to elicit Alaska Native (AN) community member and AN-serving healthcare providers’ knowledge and perspectives on the CPT1A Arctic variant. Focus groups with community members and healthcare providers were held in two regions of Alaska between October 2018 and January 2019. Thematic analysis was used to identify recurring constructs. Knowledge and understanding about the CPT1A Arctic variant and its health impact varied, and participants were interested in learning more about it. Additional education for healthcare professionals was recommended to improve providers’ ability to communicate with family caregivers about the Arctic variant. Engagement with AN community members identified opportunities to improve educational outreach via multiple modalities for providers and caregivers on the Arctic variant, which could help to increase culturally relevant guidance and avoid stigmatization, undue worry, and unnecessary intervention. Education and guidance on the care of infants and children homozygous for the CPT1A Arctic variant could improve care and reduce negative psychosocial effects.
Similar content being viewed by others
References
Alaska Department of Health (2023) Newborn bloodspot screening program. https://health.alaska.gov/dph/wcfh/Pages/bloodspot/services/default.aspx. Accessed 25 Sep 2023
Allen J, Mohatt GV, Rasmus SM, Hazel KL, Thomas L, Lindley S (2006) The tools to understand: community as co-researcher on culture-specific protective factors for Alaska Natives. J Prev Interv Commun 32(1-2):41–59. https://doi.org/10.1300/J005v32n01_04
Barrera M Jr, Castro FG, Strycker LA, Toobert DJ (2013) Cultural adaptations of behavioral health interventions: a progress report. J Consult Clin Psychol 81(2):196–205. https://doi.org/10.1037/a0027085
Bennett MJ, Santani AB (2016) Carnitine palmitoyltransferase 1A deficiency
Blabey MH, Gessner BD (2009) Three maternal risk factors associated with elevated risk of postneonatal mortality among Alaska Native population. Mater Child Health J 13(2):222–230. https://doi.org/10.1007/s10995-008-0338-0
Bougnères P-F, Saudubray J-M, Marsac C, Bernard O, Odièvre M, Girard J (1981) Fasting hypoglycemia resulting from hepatic carnitine palmitoyl transferase deficiency. J Pediat 98(5):742–746. https://doi.org/10.1016/s0022-3476(81)80834-7
Boyd-Ball AJ (2003) A Culturally responsive, family-enhanced intervention model. alcoholism: clinical &. Experimen Res 27(8):1356–1360. https://doi.org/10.1097/01.alc.0000080166.14054.7c
Bruden DJ, Singleton R, Hawk CS, Bulkow LR, Bentley S, Anderson LJ, Herrmann L, Chikoyak L, Hennessy TW (2015) Eighteen years of respiratory syncytial virus surveillance: changes in seasonality and hospitalization rates in Southwestern Alaska Native Children. Pediatr Infect Dis J 34(9):945–950. https://doi.org/10.1097/inf.0000000000000772
Burke W, Beans JA, Cho MK, Garrison NA, Hiratsuka V, Hopkins S, Spicer PG, Tsosie KS, Woodahl EL, Yracheta JM, Thummel K (2022) Values and practices to strengthen genetic research partnerships with indigenous communities. Prog Commun Health Partner 16(4):583–592. https://doi.org/10.1353/cpr.2022.0079
Clemente FJ, Cardona A, Inchley CE, Peter BM, Jacobs G, Pagani L, Lawson DJ, Antão T, Vicente M, Mitt M (2014) A selective sweep on a deleterious mutation in CPT1A in Arctic populations. Am J Human Genet 95(5):584–589
Collins SA, Edmunds S, Akearok GH, Thompson JR, Erickson AC, Hildes-Ripstein E, Miners A, Somerville M, Goldfarb DM, Rockman-Greenberg C, Arbour L (2021a) Association of the CPT1A p.P479L metabolic gene variant with childhood respiratory and other infectious illness in Nunavut. Front Pediatr 9:678553. https://doi.org/10.3389/fped.2021.678553
Collins SA, Hildes-Ripstein GE, Thompson JR, Edmunds S, Miners A, Rockman-Greenberg C, Arbour L (2021b) Neonatal hypoglycemia and the CPT1A P479L variant in term newborns: a retrospective cohort study of Inuit newborns from Kivalliq Nunavut. Paediatr Child Health 26(4):218–227. https://doi.org/10.1093/pch/pxaa039
Collins SA, Sinclair G, McIntosh S, Bamforth F, Thompson R, Sobol I, Osborne G, Corriveau A, Santos M, Hanley B, Greenberg CR, Vallance H, Arbour L (2010) Carnitine palmitoyltransferase 1A (CPT1A) P479L prevalence in live newborns in Yukon, Northwest Territories, and Nunavut. Molecular Genet Metab 101(2-3):200–204. https://doi.org/10.1016/j.ymgme.2010.07.013
Collins SA, Surmala P, Osborne G, Greenberg C, Bathory LW, Edmunds-Potvin S, Arbour L (2012) Causes and risk factors for infant mortality in Nunavut, Canada 1999–2011. BMC pediatrics 12(1):1–8
CPT1A Arctic Variant for Health care providers (2020) Alaska Native Tribal Health Consortium. https://www.youtube.com/watch?v=ZBJB6gLAr4Q. Accessed March 4, 2022
Daack-Hirsch S, Driessnack M, Hanish A, Johnson VA, Shah LL, Simon CM, Williams JK (2013) ‘Information is information’: a public perspective on incidental findings in clinical and research genome-based testing. Clin Genet 84(1):11–18. https://doi.org/10.1111/cge.12167
Foulks EF (1989) Misalliances in the Barrow Alcohol Study. Am Indian Alsk Native Mental health Res 2(3):7–17
Gessner BD, Gillingham MB, Johnson MA, Richards CS, Lambert WE, Sesser D, Rien LC, Hermerath CA, Skeels MR, Birch S (2011) Prevalence and distribution of the c. 1436C→ T sequence variant of carnitine palmitoyltransferase 1A among Alaska Native infants. J Pediat 158(1):124–129
Gessner BD, Gillingham MB, Wood T, Koeller DM (2013) Association of a genetic variant of carnitine palmitoyltransferase 1A with infections in Alaska Native children. J Pediat 163(6):1716–1721
Gessner BD, Wood T, Johnson MA, Richards CS, Koeller DM (2016) Evidence for an association between infant mortality and homozygosity for the arctic variant of carnitine palmitoyltransferase 1A. Genet Med 18(9):933–939
Gillingham MB, Hirschfeld M, Lowe S, Matern D, Shoemaker J, Lambert WE, Koeller DM (2011) Impaired fasting tolerance among Alaska native children with a common carnitine palmitoyltransferase 1A sequence variant. Molecular Genet Metab 104(3):261–264. https://doi.org/10.1016/j.ymgme.2011.06.017
Golnick C, Asay E, Provost E, Van Liere D, Bosshart C, Rounds-Riley J, Cueva K, Hennessy TW (2012) Innovative primary care delivery in rural Alaska: a review of patient encounters seen by community health aides. Int J Circump Health 71(1):18543. https://doi.org/10.3402/ijch.v71i0.18543
Gottlieb K (2013) The Nuka System of Care: improving health through ownership and relationships. Int J Circumpolar Health
Greenberg CR, Dilling LA, Thompson GR, Seargeant LE, Haworth JC, Phillips S, Chan A, Vallance HD, Waters PJ, Sinclair G, Lillquist Y, Wanders RJA, Olpin SE (2009) The paradox of the carnitine palmitoyltransferase type Ia P479L variant in Canadian Aboriginal populations. Molecular Genet Metab 96(4):201–207. https://doi.org/10.1016/j.ymgme.2008.12.018
Hayeems RZ, Miller FA, Carroll JC, Little J, Allanson J, Bytautas JP, Chakraborty P, Wilson BJ (2013) Primary care role in expanded newborn screening: after the heel prick test. Can Fam Physician 59(8):861–868
Health Resources & Services Administration (2023) Recommended uniform screening panel. https://www.hrsa.gov/advisory-committees/heritable-disorders/rusp. Accessed 22 Sep 2023
Hennink MM, Kaiser BN, Marconi VC (2017) Code saturation versus meaning saturation. Qual Health Res 27(4):591–608. https://doi.org/10.1177/1049732316665344
Hiratsuka VY, Beans JA, Robinson RF, Shaw JL, Sylvester I, Dillard DA (2017) Self-Determination in Health Research: An Alaska Native Example of Tribal Ownership and Research Regulation. Int J Environ Res Public Health 14(11):1324. https://doi.org/10.3390/ijerph14111324
Lemas DJ, Wiener HW, O'Brien DM, Hopkins S, Stanhope KL, Havel PJ, Allison DB, Fernandez JR, Tiwari HK, Boyer BB (2012) Genetic polymorphisms in carnitine palmitoyltransferase 1A gene are associated with variation in body composition and fasting lipid traits in Yup'ik Eskimos [S]. J lipid res 53(1):175–184
Living with the Arctic Variant (2020) Alaska Native Tribal Health Consortium. https://www.youtube.com/watch?v=gE8CnQjZDak. Accessed March 4, 2022
Mello MM, Wolf LE (2010) The Havasupai Indian tribe case--lessons for research involving stored biologic samples. New Eng J Med 363(3):204–207. https://doi.org/10.1056/NEJMp1005203
Norton Sound Health Corporation (2017) Fiscal year 2017 annual report. https://www.nortonsoundhealth.org/wp-content/uploads/FY17-Annual-Report.pdf. Accessed 14 Oct 2023
Norton Sound Health Corporation Research (2022). https://www.nortonsoundhealth.org/about-us/research/. Accessed 3 Jan 2022
Nowell LS, Norris JM, White DE, Moules NJ (2017) Thematic analysis. Int J Qual Methods 16(1):160940691773384. https://doi.org/10.1177/1609406917733847
Owens B (2013) Canada used hungry indigenous children to study malnutrition. Nature. https://doi.org/10.1038/nature.2013.13425
Rajakumar C, Ban MR, Cao H, Young TK, Bjerregaard P, Hegele RA (2009) Carnitine palmitoyltransferase IA polymorphism P479L is common in Greenland Inuit and is associated with elevated plasma apolipoprotein A-I. J Lipid Res 50(6):1223–1228. https://doi.org/10.1194/jlr.p900001-jlr200
Sapp C, Stirn J, O'Hollearn T, Walker EA (2021) Expanding the role of educational audiologists after a failed newborn hearing screening: a quality improvement study. Am J Audio:1–11. https://doi.org/10.1044/2021_aja-21-00003
Saunkeah B, Beans JA, Peercy MT, Hiratsuka VY, Spicer P (2021) Extending research protections to tribal communities. Am J Bioethics:1–13. https://doi.org/10.1080/15265161.2020.1865477
Sinclair GB, Collins S, Popescu O, McFadden D, Arbour L, Vallance HD (2012) Carnitine palmitoyltransferase I and sudden unexpected infant death in British Columbia First Nations. Pediatrics 130(5):e1162–e1169
Southcentral Foundation (2013) The other energy crisis: arctic variant CPT1A. https://www.youtube.com/watch?v=g-JRZ7PO3yk
Wilcken B, Haas M, Joy P, Wiley V, Chaplin M, Black C, Fletcher J, McGill J, Boneh A (2007) Outcome of neonatal screening for medium-chain acyl-CoA dehydrogenase deficiency in Australia: a cohort study. Lancet 369(9555):37–42
Acknowledgements
We would like to thank the Alaska Native mothers, caregivers, and community members for partnering on this study and for sharing their perspective, as well as Southcentral Foundation and Norton Sound Health Corporation for their support.
Funding
Research reported in this publication was supported by the Eunice Kennedy Shriver National Institute of Child Health & Human Development under Award Number R01HD089951 and National Institute of General Medical Sciences under Award Numbers S06GM123545 and S06GM142122 of the National Institutes of Health. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare no competing interests.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary information
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Beans, J.A., Trinidad, S.B., Shane, A.L. et al. The CPT1A Arctic variant: perspectives of community members and providers in two Alaska tribal health settings. J Community Genet 14, 613–620 (2023). https://doi.org/10.1007/s12687-023-00684-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12687-023-00684-6